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Objective: We compared the outcomes of same sitting, robotic assisted Hybrid Coronary Artery Revascularization (HCR) with off-pump Coronary 
Artery Bypass Grafting (OPCABG) in similar patients with multi-vessel coronary artery disease.
Background: HCR is a novel procedure in select patients with multi-vessel CAD. Although there is some data on staged HCR, separated by days, the 
data on same-sitting HCR is meager.
Methods: We conducted a single center, prospective analysis comparing same sitting, robotic assisted HCR patients (n=25) to a group of 
consecutive, low-moderate risk OPCABG patients (n=27) during the study period. HCR patients underwent robotic internal mammary artery takedown 
followed by OPCABG via mini-thoracotomy. After confirming graft patency, immediate PCI on the non-bypass arteries was performed. Comparative 
analyses were performed on hospital and 30 day outcomes.
Results: The baseline characteristics were similar for the HCR vs. OPCABG groups including the severity of CAD (Syntax score 33.5+/-8.2 vs. 
34.9+/-8.2, p=0.556). Same sitting HCR was successful in all patients. Overall MACE was similar between the two groups, however the HCR group 
showed improved hospital outcomes with lower post-operative troponin levels (0.8+/-0.7 vs. 2.2+/-2.3, p<0.01), lower need for post-operative 
transfusions (12% vs. 67%, p<0.001), and shorter length of hospital stay (5.1+/-2.8 vs. 8.2+/-5.4 days, p<0.01). Propensity model analysis showed 
similar findings. The HCR group showed improved quality of life measures with shorter time to return to work/normal activities (5.3+/-3.0 vs. 8.2+/-
4.6 weeks, p=0.01).
Conclusions: Same sitting HCR appears to be feasible and may offer superior outcomes compared with standard OPCABG, further studies are 
warranted.
